Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IER3 (IEX-1) dysregulation serves as a potential prognostic factor in acute myeloid leukemia patients.

International journal of laboratory hematology - 1 Apr 2022

Ke Shandong, Zhang Xin, Xiang Xiuzhi, Lu Yalan, An Hongyu

Abstract excerpt

INTRODUCTION: Immediate early response 3 (IER3) has association with hematological malignancies' risk and prognosis, such as myelodysplastic syndrome, while its relation to acute myeloid leukemia (AML) is not clear. This study aimed to explore the correlation of IER3 with AML risk, clinical characteristics, complete remission (CR), event-free survival (EFS), and overall survival (OS). METHODS: A total of 93 de...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis Regulatory Proteins
Share to fms-Like Tyrosine Kinase 3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Leukemic

Share to Leukemia, Myeloid, Acute

Share to Membrane Proteins

Share to Myelodysplastic Syndromes

Share to Prognosis

Share to Remission Induction

Source

Open in PubMed Open full text

Identifiers

PMID: 34729939
DOI: 10.1111/ijlh.13749
PMCID: PMC9298238

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IER3 (IEX-1) dysregulation serves as a potential prognostic factor in acute myeloid leukemia patients.PMID 34729939Read ↗

Expression of immune check point gene TIM‑3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcomeSemantic proximity Read ↗

High IFITM3 expression predicts adverse prognosis in acute myeloid leukemiaSemantic proximity Read ↗

Expression of ERV3-1 in Leukocytes of Acute Myelogenous Leukemia PatientsSemantic proximity Read ↗

Construction of an acute myeloid leukemia prognostic model based on m6A-related efferocytosis-related genesSemantic proximity Read ↗

Multiple machine-learning tools identifying prognostic biomarkers for acute Myeloid LeukemiaSemantic proximity Read ↗

The potential novel immune-related prognostic factors for acute myeloid leukemiaSemantic proximity Read ↗

Detection of measurable residual disease may better predict outcomes than mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA.Semantic proximity Read ↗

A Prognostic Model of Seven Immune Genes to Predict Overall Survival in Childhood Acute Myeloid LeukemiaSemantic proximity Read ↗

The Regulatory Roles of Long Noncoding RNAs in Acute Myeloid LeukemiaSemantic proximity Read ↗

A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genesSemantic proximity Read ↗

Analysis of prognostic biomarker models of TXNIP/NLRP3/IL1B inflammasome pathway in patients with acute myeloid leukemiaSemantic proximity Read ↗

ROBO3 is a Potential Prognostic Biomarker that guides treatment option and Correlates with Immune Cell Infiltration in Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.